2011
DOI: 10.1021/ja202726y
|View full text |Cite
|
Sign up to set email alerts
|

How Does a Drug Molecule Find Its Target Binding Site?

Abstract: Although the thermodynamic principles that control the binding of drug molecules to their protein targets are well understood, detailed experimental characterization of the process by which such binding occurs has proven challenging. We conducted relatively long, unguided molecular dynamics simulations in which a ligand (the cancer drug dasatinib or the kinase inhibitor PP1) was initially placed at a random location within a box that also contained a protein (Src kinase) to which that ligand was known to bind.… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

31
678
3
4

Year Published

2012
2012
2021
2021

Publication Types

Select...
6
4

Relationship

0
10

Authors

Journals

citations
Cited by 600 publications
(716 citation statements)
references
References 11 publications
31
678
3
4
Order By: Relevance
“…This result provides a picture different from that provided by standard protein−drug interaction. 61 While, on average, the contact surface between a small-molecule ligand and its protein receptor is 300−1000 Å 2 , 62 we find that the average contact surface of NQTrp with Aβ42, calculated using all conformations, is only 259 ± 7.4 Å 2 (with a minimum of 68 Å 2 and a maximum of 396 Å 2 ). Taken together, our results indicate that there is room to design more efficient drugs targeting Aβ42 dimer against AD.…”
Section: ■ Conclusionmentioning
confidence: 81%
“…This result provides a picture different from that provided by standard protein−drug interaction. 61 While, on average, the contact surface between a small-molecule ligand and its protein receptor is 300−1000 Å 2 , 62 we find that the average contact surface of NQTrp with Aβ42, calculated using all conformations, is only 259 ± 7.4 Å 2 (with a minimum of 68 Å 2 and a maximum of 396 Å 2 ). Taken together, our results indicate that there is room to design more efficient drugs targeting Aβ42 dimer against AD.…”
Section: ■ Conclusionmentioning
confidence: 81%
“…PKA belongs to the AGC family of kinases, which are typically characterized by a cis-regulatory C-terminal tail (20). Recently multiple-microsecond timescale simulations have been performed on several tyrosine kinases (21)(22)(23)(24), and a Markov model was constructed for activation of Src kinase that Significance Protein kinases represent a critically important family of regulatory enzymes. Their activity can be altered by mutations and binding events distant from the active site.…”
mentioning
confidence: 99%
“…2 [28] incorporated into the Schrödinger suite 9.3 [29]. Each simulation was carried out for 5 nanoseconds (ns).…”
Section: Molecular Dynamicsmentioning
confidence: 99%